Home > News > Labopharm reports results for second quarter fiscal 2004
July 28th, 2004
Labopharm reports results for second quarter fiscal 2004
Labopharm Inc. (TSX: DDS) today reported its results for the second quarter of fiscal 2004 ended June 30, 2004. Net loss for the second quarter of fiscal 2004 was $7.1 million, or $0.18 per share, compared with $8.8 million, or $0.28 per share, for the second quarter of fiscal 2003.
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Acid folic was used in the production of the nanogel as targeting agent in drug delivery. The nanogel can be used in the treatment of cancer as a stable nanocarrier. Stability of nanocarriers is an important issue in target delivery mechanisms. Most of nanocarriers, due to their March 17th, 2014
Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014
Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014